Description
The debate raised this alternative mechanism where TFEB activation might worsen pathology rather than improve it, but provided no experimental evidence either way. This could fundamentally alter the therapeutic hypothesis and requires direct testing.
Source: Debate session sess_SDA-2026-04-10-gba-pd (Analysis: gba-pd)
Evidence summary
Resolved by hypothesis h-var-08a4d5c07a: Gut Microbiome Remodeling to Prevent Systemic NLRP3 Priming in Neurodegeneration. Score: 0.907. Supporting PMIDs: 33875891, 30610225, 31748742, 27519954, 33741860.